Site Listing

Please choose the site that is most convenient for you

Study Name: A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined
23 locations found